BioCryst: Q1 Earnings Snapshot

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $35.4 million in its first quarter.

The Durham, North Carolina-based company said it had a loss of 17 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The drugmaker posted revenue of $92.8 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $85.6 million.

The company’s shares closed at $4.45. A year ago, they were trading at $8.47.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BCRX at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up